Mammary hamartoma: is ultrasound-guided vacuum-assisted breast biopsy sufficient for its treatment?

Hu, Huayu; Zhang, Mengke; Liu, Yuan; Li, Xiru; Liu, Gang; Wang, Zhili

doi:10.21037/gs-20-437

Cited by 6 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, the lesion size for US-VAE may be more flexible for hamartoma. Hu et al ( 20 ) also reported that the complete excision rate for the treatment hamartoma is 96.8% (30/31) and believed that US-VAE is an alternative treatment to open surgery, especially for large mammary hamartoma. In this study, we found that US-VAE could treat fibroadenoma, adenosis, and hamartoma with great efficacy, which indicates that US-VAE is an alternative treatment to open surgery.…”

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of percutaneous ultrasound—guided vacuum—assisted excision for the treatment of clinical benign breast lesions larger than 3 cm: a retrospective cohort study

Wang¹,

Jin²,

Zhang³

et al. 2022

Ann Transl Med

View full text Add to dashboard Cite

Background: Breast ultrasound-guided vacuum-assisted excision (US-VAE) has become a scarless solution for the removal of benign breast lesions. This procedure is now favored by more and more female patients for its satisfactory cosmetic outcome and few postoperative complications. However, controversy have been raised regarding its efficacy and safety in treating larger benign breast lesions. This study aimed to evaluate whether US-VAE is sufficient for the treatment of clinical benign breast lesions larger than 3 cm and to investigate the lesion features that affect the complete excision rate and hematoma occurrence rate.

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of percutaneous ultrasound—guided vacuum—assisted excision for the treatment of clinical benign breast lesions larger than 3 cm: a retrospective cohort study

Wang¹,

Jin²,

Zhang³

et al. 2022

Ann Transl Med

View full text Add to dashboard Cite

show abstract

“…Unfortunately, VABB is not without complications; to minimize the incidence of possible complications, VABB is not recommended in cases with scattered MCC, lesions close to the skin, areola and nipple complex, or chest wall due to the difficulty in access and increased risk of skin dehiscence. While Park et al reported a complication rate of 2.5% including bleeding, hematoma formation, skin injury, and dimple formation, or even pneumothorax [15], Hu et al reported pain in 22.6%, hematomas formation in 9.7%, and ecchymosis in 3.2% [16]. US-VAB is associated with a slightly higher risk of bleeding when compared to SVAB, which can be attributed to the lack of breast compression during the US-guided procedure [17].…”

Section: Discussionmentioning

confidence: 99%

Vacuum-Assisted Breast Biopsy System: No Innovation Without Evaluation

Monib¹,

Mukerji²,

Narula³

2021

Cureus

View full text Add to dashboard Cite

Background Vacuum-assisted breast biopsy (VABB) has recently been gaining more popularity as a modality to reach the final diagnosis, especially in indeterminate breast lesions, resulting in a decreased number of surgical interventions and unnecessary follow-ups. Objective While our primary aim was to look into the outcomes of the VABB technique, our secondary aim was to assess the impact of the method on changes in patients' management. Patients and methods This study was a retrospective database analysis of vacuum-assisted biopsies (VABs) carried out at our breast unit during the period between January 2011 and January 2018. All our cases were image-guided; the caliber of vacuum-assisted needles used was 8 gauge (G) and 11 G. Patient demographics, lesion characteristics, and outcomes were retrieved from patients' notes and the hospital database. Results A total of 122 female patients were included in the analysis, out of whom 41.8% (51 patients) were screendetected, and 58.1% (71 patients) were symptomatic presentations. The mean lesion size on imaging was 14.8 mm (SD: 12.6); 50% (61 patients) had stereotactic vacuum-assisted breast biopsy (SVAB), and 50% (61 patients) had ultrasound-guided vacuum-assisted breast biopsy (US-VAB). Post-procedure histology was upgraded in 19.6% (24 patients), downgraded in 18.8% (23 patients), and remained unchanged in 61.4% (75 patients). Conclusion VABB is a safe and efficient procedure for the diagnosis and management of indeterminate and suspicious breast lesions. It provides an adequate amount of tissue, which can help in upgrading or downgrading histopathologically diagnosed patients, thereby decreasing the need for surgery.

show abstract

“…Hamartoma is generally a benign disease but may rarely be present with breast malignancy (11,12). An excisional biopsy is usually required to differentiate a hamartoma from other benign breast lesions, such as fibroadenoma, lipoma, and cystosarcoma phyllodes (13).…”

mentioning

confidence: 99%

Breast Hamartoma: Clinical, Radiological, and Histopathological Evaluation

Tazeoğlu¹,

Dağ²,

Arslan³

et al. 2021

EJBH

View full text Add to dashboard Cite

Objective: Breast hamartomas are rare, benign, and slow-growing breast tumors that can be definitively diagnosed by combining the results of clinical, radiological, and histopathological examination. This study aimed to evaluate the clinical, radiological, and histopathological features of hamartomas and summarize our clinical approach to hamartomas. Materials and Methods:Patients diagnosed with breast hamartoma between 2010 and 2020 in our clinic were retrospectively analyzed. Demographic information, clinical examination, radiological findings, histopathological features, changes during follow-up, and follow-up data were obtained and analyzed.Results: Of the 1,429 patients operated on in our clinic for benign breast diseases between January 2010 and March 2020, 39 (2.7%) were diagnosed with breast hamartomas with histopathological examination. All patients were women with a median age of 37 (19-62) years. Most of the patients (64%) were in the premenopausal period. Radiological examinations were conducted using mammography (66%), breast ultrasonography (100%), and breast magnetic resonance imaging (48%). Biopsy was performed in 14 preoperative patients, and nine (64%) patients were diagnosed with hamartoma. All patients were operated on; 37 patients underwent a lumpectomy, and two had a mastectomy. No patients had hamartoma recurrence during an average follow-up period of 39 months. Conclusion:Hamartomas are similar to other benign breast pathologies. Definitive diagnosis can be achieved by combining the results of clinical, radiological, and histopathological examination. Given its similar composition to normal breast tissue, hamartoma has a low rate of malignancy. Definitive diagnosis and appropriate surgical treatment are required.

show abstract

Mammary hamartoma: is ultrasound-guided vacuum-assisted breast biopsy sufficient for its treatment?

Cited by 6 publications

References 21 publications

Efficacy and safety of percutaneous ultrasound—guided vacuum—assisted excision for the treatment of clinical benign breast lesions larger than 3 cm: a retrospective cohort study

Efficacy and safety of percutaneous ultrasound—guided vacuum—assisted excision for the treatment of clinical benign breast lesions larger than 3 cm: a retrospective cohort study

Vacuum-Assisted Breast Biopsy System: No Innovation Without Evaluation

Breast Hamartoma: Clinical, Radiological, and Histopathological Evaluation

Contact Info

Product

Resources

About